The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice

被引:237
作者
Hsieh, J. [2 ,3 ]
Longuet, C. [4 ]
Baker, C. L. [3 ]
Qin, B. [5 ]
Federico, L. M. [3 ]
Drucker, D. J. [1 ,4 ]
Adeli, K. [2 ,3 ]
机构
[1] Mt Sinai Hosp SLRI, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Dept Biochem, Toronto, ON, Canada
[3] Univ Toronto, Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada
[4] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada
[5] ARS, Beltsville Human Nutr Res Ctr, USDA, Beltsville, MD USA
关键词
Dipeptidyl peptidase-4; Incretins; Lipids; Triacylglycerol; DIPEPTIDYL PEPTIDASE-4 INHIBITOR; INSULIN-RESISTANCE; PARTICLE CHOLESTEROL; GLUCOSE-HOMEOSTASIS; ENERGY-EXPENDITURE; ANIMAL-MODEL; DOUBLE-BLIND; PROTEIN; POLYPEPTIDE; SITAGLIPTIN;
D O I
10.1007/s00125-009-1611-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors attenuate postprandial lipaemia through mechanisms that remain unclear. As dyslipidaemia is a contributing risk factor for cardiovascular disease in type 2 diabetes, we examined the mechanisms linking pharmacological and physiological regulation of GLP-1 action to control of postprandial lipid metabolism. Postprandial lipid synthesis and secretion were assessed in normal and fructose-fed hamsters and in wild-type mice that were treated with or without sitagliptin. Apolipoprotein B-48 (ApoB-48) synthesis and secretion were also examined in primary enterocyte cultures. The importance of exogenous vs endogenous GLP-1R signalling for regulation of intestinal lipoprotein synthesis and secretion was assessed in mice and hamsters treated with the GLP-1R agonist exendin-4, the GLP-1R antagonist exendin(9-39) and in Glp1r (+/+) vs Glp1r (-/-) mice. Sitagliptin decreased fasting plasma triacylglycerol, predominantly in the VLDL fraction, as well as postprandial triacylglycerol-rich lipoprotein (TRL)-triacylglycerol, TRL-cholesterol and TRL-ApoB-48 in hamsters and mice. GLP-1R activation with exendin-4 alone also decreased plasma and TRL-ApoB-48 in hamsters and mice, and reduced secretion of ApoB-48 in hamster enterocyte cultures. Conversely, blockade of endogenous GLP-1R signalling by the antagonist exendin(9-39) or genetic elimination of GLP-1R signalling in Glp1r (-/-) mice enhanced TRL-ApoB-48 secretion in vivo. Co-administration of exendin(9-39) also abolished the hypolipidaemic effect of sitagliptin. Potentiation of endogenous incretin action via DPP-4 inhibition or pharmacological augmentation of GLP-1R signalling reduces intestinal secretion of triacylglycerol, cholesterol and ApoB-48. Moreover, endogenous GLP-1R signalling is essential for the control of intestinal lipoprotein biosynthesis and secretion.
引用
收藏
页码:552 / 561
页数:10
相关论文
共 33 条
[1]   Efficacy and safety of incretin therapy in type 2 diabetes - Systematic review and meta-analysis [J].
Amori, Renee E. ;
Lau, Joseph ;
Pittas, Anastassios G. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (02) :194-206
[2]   Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes [J].
Aschner, Pablo ;
Kipnes, Mark S. ;
Lunceford, Jared K. ;
Sanchez, Matilde ;
Mickel, Carolyn ;
Williams-Herman, Debora E. .
DIABETES CARE, 2006, 29 (12) :2632-2637
[3]   A recombinant human glucagon-like peptide (GLP)-1-albumin protein (Albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis [J].
Baggio, LL ;
Huang, QL ;
Brown, TJ ;
Drucker, DJ .
DIABETES, 2004, 53 (09) :2492-2500
[4]   Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure [J].
Baggio, LL ;
Huang, QL ;
Brown, TJ ;
Drucker, DJ .
GASTROENTEROLOGY, 2004, 127 (02) :546-558
[5]   Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers [J].
Bergman, AJ ;
Stevens, C ;
Zhou, YY ;
Yi, BM ;
Laethem, M ;
De Smet, M ;
Snyder, K ;
Hilliard, D ;
Tanaka, W ;
Zeng, W ;
Tanen, M ;
Wang, AQ ;
Chen, L ;
Winchell, G ;
Davies, MJ ;
Ramael, S ;
Wagner, JA ;
Herman, GA .
CLINICAL THERAPEUTICS, 2006, 28 (01) :55-72
[6]   Dipeptidyl-Peptidase-IV Inhibition Augments Postprandial Lipid Mobilization and Oxidation in Type 2 Diabetic Patients [J].
Boschmann, Michael ;
Engeli, Stefan ;
Dobberstein, Kerstin ;
Budziarek, Petra ;
Strauss, Anke ;
Boehnke, Jana ;
Sweep, Fred C. G. J. ;
Luft, Friedrich C. ;
He, YanLing ;
Foley, James E. ;
Jordan, Jens .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (03) :846-852
[7]   The biology of incretin hormones [J].
Drucker, DJ .
CELL METABOLISM, 2006, 3 (03) :153-165
[8]   EFFECT OF EXOGENOUS OR ENDOGENOUS GASTRIC-INHIBITORY POLYPEPTIDE (GIP) ON PLASMA TRIGLYCERIDE RESPONSES IN RATS [J].
EBERT, R ;
NAUCK, M ;
CREUTZFELDT, W .
HORMONE AND METABOLIC RESEARCH, 1991, 23 (11) :517-521
[9]   Intestinal insulin resistance and aberrant production of apolipoprotein b48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia - Evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-fed hamster intestine [J].
Federico, LM ;
Naples, M ;
Taylor, D ;
Adeli, K .
DIABETES, 2006, 55 (05) :1316-1326
[10]   Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance -: Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction [J].
Haidari, M ;
Leung, N ;
Mahbub, F ;
Uffelman, KD ;
Kohen-Avramoglu, R ;
Lewis, GF ;
Adeli, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) :31646-31655